Comparative effectiveness of six antiviral agents in Herpes simplex type 1 infection of mice.
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use* / Q000633:toxicity; D003561:Cytarabine / Q000627:therapeutic use / Q000633:toxicity; D004347:Drug Interactions; D005260:Female; D006561:Herpes Simplex / Q000188:drug therapy*; D007065:Idoxuridine / Q000627:therapeutic use / Q000633:toxicity; D007372:Interferons / Q000627:therapeutic use / Q000633:toxicity; D051379:Mice; D063065:Organophosphonates / Q000627:therapeutic use / Q000633:toxicity; D009943:Organophosphorus Compounds / Q000627:therapeutic use / Q000633:toxicity; D011070:Poly I-C / Q000627:therapeutic use / Q000633:toxicity; D014740:Vidarabine / Q000627:therapeutic use / Q000633:toxicity
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003561:Cytarabine; D007372:Interferons; D014740:Vidarabine; D007065:Idoxuridine; D011070:Poly I-C